The New York Times has issued an apology to Chinese professional tennis player Li Na after they indicated in one of their reports that Li had taken an early retirement after struggling with steroid use.
According to The South China Morning Post, the lengthy profile piece, entitled 'Li Na, China's Tennis Rebel', was originally published on August 22.
In it, reporter Brook Larmer wrote that Li's two-year break from the tennis world in 2002 had been caused by a number of different factors, including the burnout from excessive training, the outrage at her coaches' attempts to squelch her romance with a male teammate named Jiang Shan, and steroid use, the report said.
News of the alleged steroid pill use spread throughout Chinese media shortly after The New York Times piece was published, the report added.
The New York Times' reporter later revealed that a mis-translation for the Chinese term for 'hormone medication,' had lead to the confusion, while the paper apologised for it, the report further said.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
